<P><JC>The Pacific Standard</JC>
<P>
<P><JC>ACCIDENT AT VERSALIFE SETS BACK AMBROSIA PRODUCTION<JC>
<P>
<P>A significant accident at Versalife's Hong Kong facilities has added to the company's growing list of woes. Although the company is being somewhat secretive with details, a spokesperson was quoted as saying, "This accident in our biotech manufacturing labs has cost us invaluable resources and time. With the Grey Death a widespread threat, this has substantially impeded our ability to research and manufacture life-saving pharmaceuticals for delivery around the world. We are not ready to say at this time what caused the incident, but we are seriously investigating the matter and cooperating with local authorities."
<P>
<P>When we reached out to an anonymous source within the company, they revealed: "The losses have been catastrophic, in terms of physical damage to the labs, and to workplace stability. It's insane. Who would destroy half of our research department? We're trying to help people."
<P>
<P>This is a developing story, and we hope to provide our readers with more details as we learn them.